Colleen D. McDermott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Colleen D. McDermott has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Douglass S. Hale
Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Methodist Hospital/Indiana University Health, Indianapolis IN
9 shared publicationsColin L. Terry
Department of Biostatistics, Methodist Hospital/Indiana University Health, Indianapolis IN
8 shared publicationsPatrick J. Woodman
Female Pelvic Medicine and Reconstructive Surgery, Department of Obstetrics and Gynecology, Methodist Hospital/Indiana University Health, Indianapolis IN
7 shared publicationsDanny Lovatsis
Division of Urogynecology, Department of Obstetrics and Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
4 shared publicationsAnouk Benseler
Department of Obstetrics and Gynecology
3 shared publicationsGeorge Tomlinson
Department of Medicine, University Health Network and Mt Sinai Hospital, and Institute of Health Policy, Management and Evaluation, University of Toronto
3 shared publications
Latest Publications
- Open Access
- 13 January 2025
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 32 (6) , 555-561
Does Intravenous Tranexamic Acid Reduce Blood Loss at the Time of Total Colpocleisis? A Randomized Double-Blind Placebo-Controlled Trial
- 13 January 2025
- Published by Elsevier in Journal of Minimally Invasive Gynecology
- Vol. 32 (6) , 555-561
Open AccessDoes Intravenous Tranexamic Acid Reduce Blood Loss at the Time of Total Colpocleisis? A Randomized Double-Blind Placebo-Controlled Trial
- 10 May 2024
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 30 (10) , 805-813
Cost Analysis of Bladder Catheterization After Pelvic Floor Surgery
Importance: Approximately 15–45% of female patients develop transient postoperative urinary retention (POUR) following pelvic reconstructive surgery. Catheter options for bladder drainage include transurethral indwelling catheter (TIC), intermittent self-catheterization (ISC), and suprapubic tube (SPT). Each strategy has risks and benefits; none have been shown to be clinically superior, and to date, no comprehensive comparative economic analysis has been published. Objective: The objective of this study was to evaluate the cost of these different bladder catheterization strategies after transvaginal pelvic surgery. Study Design: A Canadian universal single-payer (government funded) health system perspective was taken, and a decision tree model was constructed to evaluate the costs associated with each catheterization strategy over a 6-week horizon. Base-cases were set based on recently published clinical data of our institutions, 2 academic tertiary care centers, and based on systematic reviews and meta-analyses. Costs were established in consultation with process stakeholders, in addition to published values. Results: The average cost calculated for management of transient POUR after outpatient pelvic reconstructive surgery was 150.69 CAD (median 154.86; interquartile range [IQR] 131.30–176.33) for TIC, 162.28 CAD (median 164.72; IQR 144.36–189.39) for ISC and 255.67 CAD (median 270.63; IQR 234.32–276.82) for SPT. In costing inpatient surgical data, the average cost calculated was 134.22 CAD (median 123.61; IQR 108.87–151.85) for TIC and 224.61 CAD (median 216.07; IQR 203.86–231.23) for SPT. Conclusion: TIC and ISC were found to be significantly less costly than SPT in managing transient POUR following transvaginal pelvic reconstructive surgery.
- 10 May 2024
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 30 (10) , 805-813
Cost Analysis of Bladder Catheterization After Pelvic Floor Surgery
Importance: Approximately 15–45% of female patients develop transient postoperative urinary retention (POUR) following pelvic reconstructive surgery. Catheter options for bladder drainage include transurethral indwelling catheter (TIC), intermittent self-catheterization (ISC), and suprapubic tube (SPT). Each strategy has risks and benefits; none have been shown to be clinically superior, and to date, no comprehensive comparative economic analysis has been published. Objective: The objective of this study was to evaluate the cost of these different bladder catheterization strategies after transvaginal pelvic surgery. Study Design: A Canadian universal single-payer (government funded) health system perspective was taken, and a decision tree model was constructed to evaluate the costs associated with each catheterization strategy over a 6-week horizon. Base-cases were set based on recently published clinical data of our institutions, 2 academic tertiary care centers, and based on systematic reviews and meta-analyses. Costs were established in consultation with process stakeholders, in addition to published values. Results: The average cost calculated for management of transient POUR after outpatient pelvic reconstructive surgery was 150.69 CAD (median 154.86; interquartile range [IQR] 131.30–176.33) for TIC, 162.28 CAD (median 164.72; IQR 144.36–189.39) for ISC and 255.67 CAD (median 270.63; IQR 234.32–276.82) for SPT. In costing inpatient surgical data, the average cost calculated was 134.22 CAD (median 123.61; IQR 108.87–151.85) for TIC and 224.61 CAD (median 216.07; IQR 203.86–231.23) for SPT. Conclusion: TIC and ISC were found to be significantly less costly than SPT in managing transient POUR following transvaginal pelvic reconstructive surgery.
- 19 March 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (4) , 883-892
Optimizing practices to prevent urinary tract infection after cystoscopy and urodynamics in women: A quality improvement study
Objective: The objective of this study was to reduce the incidence of urinary tract infection (UTI) in women undergoing outpatient cystoscopy and/or urodynamic studies (UDS) at our centre by identifying and then altering modifiable risk factors through an analysis of incidence variability among physicians.Methods: This was a quality improvement study involving adult women undergoing outpatient cystoscopy and/or UDS at an academic tertiary urogynecology practice. Prophylactic practices for cystoscopy/UDS were surveyed and division and physician‐specific UTI rates following cystoscopy/UDS were established. In consultation with key stakeholders, this delineated change concepts based on associations between prophylactic practices and UTI incidence, which were then implemented while monitoring counterbalance measures.Results: Two “Plan‐Do‐Study‐Act‐Cycles” were conducted whereby 212 and 210 women were recruited, respectively. Change concepts developed and implemented were: (1) to perform routine urine cultures at the time of these outpatient procedures, and (2) to withhold routine prophylactic antibiotics for outpatient cystoscopy/UDS, except in patients with signs of cystitis. There was no change in the incidence of early presenting UTI (9.0% vs. 9.2%, p = 0.680), but there were significantly fewer antibiotic‐related adverse events reported (8.5% vs. 1.5%, p = 0.001). There was no significant change in the total incidence of UTI rates between cycles (7.8% vs. 5.6%, p = 0.649).Conclusions: No specific strategies to decrease the incidence of UTI following outpatient cystoscopy/UDS were identified, however, risk factor‐specific antibiotic prophylaxis, as opposed to universal antibiotic prophylaxis, did not increase UTI incidence.
- 19 March 2024
- Published by Wiley in Neurourology and Urodynamics
- Vol. 43 (4) , 883-892
Optimizing practices to prevent urinary tract infection after cystoscopy and urodynamics in women: A quality improvement study
Objective: The objective of this study was to reduce the incidence of urinary tract infection (UTI) in women undergoing outpatient cystoscopy and/or urodynamic studies (UDS) at our centre by identifying and then altering modifiable risk factors through an analysis of incidence variability among physicians.Methods: This was a quality improvement study involving adult women undergoing outpatient cystoscopy and/or UDS at an academic tertiary urogynecology practice. Prophylactic practices for cystoscopy/UDS were surveyed and division and physician‐specific UTI rates following cystoscopy/UDS were established. In consultation with key stakeholders, this delineated change concepts based on associations between prophylactic practices and UTI incidence, which were then implemented while monitoring counterbalance measures.Results: Two “Plan‐Do‐Study‐Act‐Cycles” were conducted whereby 212 and 210 women were recruited, respectively. Change concepts developed and implemented were: (1) to perform routine urine cultures at the time of these outpatient procedures, and (2) to withhold routine prophylactic antibiotics for outpatient cystoscopy/UDS, except in patients with signs of cystitis. There was no change in the incidence of early presenting UTI (9.0% vs. 9.2%, p = 0.680), but there were significantly fewer antibiotic‐related adverse events reported (8.5% vs. 1.5%, p = 0.001). There was no significant change in the total incidence of UTI rates between cycles (7.8% vs. 5.6%, p = 0.649).Conclusions: No specific strategies to decrease the incidence of UTI following outpatient cystoscopy/UDS were identified, however, risk factor‐specific antibiotic prophylaxis, as opposed to universal antibiotic prophylaxis, did not increase UTI incidence.
- Open Access
- 1 April 2023
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 29 (4) , 381-396
Postoperative Urinary Retention
This clinical consensus statement on the management of postoperative (<6 weeks) urinary retention (POUR) reflects statements drafted by content experts from the American Urogynecologic Society’s POUR writing group. The writing group used a modified Delphi process to evaluate statements developed from a structured literature search and assessed for consensus. After the definition of POUR was established, a total of 37 statements were assessed in the following 6 categories: (1) incidence of POUR, (2) medications, (3) patient factors, (4) surgical factors, (5) urodynamic testing, and (6) voiding trials. Of the 37 original statements, 34 reached consensus and 3 were omitted.
- 1 April 2023
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 29 (4) , 381-396
Open AccessPostoperative Urinary Retention
This clinical consensus statement on the management of postoperative (<6 weeks) urinary retention (POUR) reflects statements drafted by content experts from the American Urogynecologic Society’s POUR writing group. The writing group used a modified Delphi process to evaluate statements developed from a structured literature search and assessed for consensus. After the definition of POUR was established, a total of 37 statements were assessed in the following 6 categories: (1) incidence of POUR, (2) medications, (3) patient factors, (4) surgical factors, (5) urodynamic testing, and (6) voiding trials. Of the 37 original statements, 34 reached consensus and 3 were omitted.
- Open Access
- 9 March 2023
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 29 (9) , 732-739
Patient-Specific Pessaries for Pelvic Organ Prolapse Using Three-Dimensional Printing: A Pilot Study
Importance: Vaginal pessaries are an effective nonsurgical treatment for pelvic organ prolapse (POP) when properly fitted. However, pessary fitting and use are often unsuccessful or imperfect. Objective: The objective of this study was to assess the feasibility of using patient-specific pessaries fabricated from three-dimensional (3D)-printed molds to improve POP symptoms and increase overall satisfaction of pessary treatment in patients using standard vaginal pessaries. Study Design: Patients undergoing POP treatment with standard vaginal pessaries were enrolled in this pilot prospective study. Patient-specific pessaries were designed and fabricated for each patient using patient input, physician input, and anatomic measurements from clinical assessment. Pessary fabrication involved injection of biocompatible liquid silicone rubber into 3D-printed molds followed by a biocompatible silicone coating. Pelvic organ prolapse symptomatic distress and pessary treatment satisfaction were evaluated before and after a 3-week patient-specific pessary home trial using the validated Pelvic Organ Prolapse Distress Inventory-6 form and a visual analog scale, respectively. Results: Eight women were included in this study. Changing from standard pessary to patient-specific pessary treatment was associated with an improvement in prolapse symptoms on the Pelvic Organ Prolapse Distress Inventory-6 (median change, −3.5; interquartile range, −5 to −2.5; P = 0.02) and an increase in overall pessary satisfaction on a visual analog scale (median change, +2.0; interquartile range, +1.0 to +3.0; P = 0.02). All patients reported either an improvement or no change in pessary ease of use, comfort, and the feeling of support provided by the pessary. Conclusion: Patient-specific vaginal pessaries are a promising alternative to standard pessaries for alleviating POP symptoms and improving patient satisfaction with pessary use.
- 9 March 2023
- Published by Wolters Kluwer Health in Urogynecology
- Vol. 29 (9) , 732-739
Open AccessPatient-Specific Pessaries for Pelvic Organ Prolapse Using Three-Dimensional Printing: A Pilot Study
Importance: Vaginal pessaries are an effective nonsurgical treatment for pelvic organ prolapse (POP) when properly fitted. However, pessary fitting and use are often unsuccessful or imperfect. Objective: The objective of this study was to assess the feasibility of using patient-specific pessaries fabricated from three-dimensional (3D)-printed molds to improve POP symptoms and increase overall satisfaction of pessary treatment in patients using standard vaginal pessaries. Study Design: Patients undergoing POP treatment with standard vaginal pessaries were enrolled in this pilot prospective study. Patient-specific pessaries were designed and fabricated for each patient using patient input, physician input, and anatomic measurements from clinical assessment. Pessary fabrication involved injection of biocompatible liquid silicone rubber into 3D-printed molds followed by a biocompatible silicone coating. Pelvic organ prolapse symptomatic distress and pessary treatment satisfaction were evaluated before and after a 3-week patient-specific pessary home trial using the validated Pelvic Organ Prolapse Distress Inventory-6 form and a visual analog scale, respectively. Results: Eight women were included in this study. Changing from standard pessary to patient-specific pessary treatment was associated with an improvement in prolapse symptoms on the Pelvic Organ Prolapse Distress Inventory-6 (median change, −3.5; interquartile range, −5 to −2.5; P = 0.02) and an increase in overall pessary satisfaction on a visual analog scale (median change, +2.0; interquartile range, +1.0 to +3.0; P = 0.02). All patients reported either an improvement or no change in pessary ease of use, comfort, and the feeling of support provided by the pessary. Conclusion: Patient-specific vaginal pessaries are a promising alternative to standard pessaries for alleviating POP symptoms and improving patient satisfaction with pessary use.
- 5 January 2023
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 130 (6) , 610-618
Comparing vitamin B2 versus 5% dextrose in water for optimal ureteric jet visualisation at the time of pelvic reconstructive surgery: A randomised controlled trial
Objective: To compare preoperative vitamin B2 versus intraoperative cystoscopy distension using 5% dextrose in water (D5W) for ureteric jet visualisation during pelvic reconstructive surgery.Design: Double‐blinded, randomised controlled trial.Setting: Three tertiary hospitals in Toronto, Canada.Population: Adult women undergoing pelvic reconstructive surgery.Methods: Patients were randomised to receive 100 mg of vitamin B2 preoperatively versus bladder distension with D5W intraoperatively.Main outcomes: The primary outcome was the rate of accurate detection of bilateral ureteric jets during cystoscopy. Secondary outcomes included the time elapsed until visualisation, use of intravenous furosemide or fluorescein to assist with visualisation, surgeon satisfaction, and positive urine culture 1 week after surgery.Results: The intervention was completed by 236 patients (vitamin B2 n = 117, D5W n = 119). Preoperative characteristics were similar across groups. Accurate detection of both ureteric jets was high in both groups (vitamin B2 97.4% vs. D5W 90.8%, p = 0.051). The vitamin B2 group had significantly lower use of fluorescein rescue compared with the D5W group (3.4% vs. 11.8%, respectively, p = 0.025). Surgeon satisfaction while using vitamin B2 was significantly higher (p < 0.001). There were no significant differences in the time elapsed until visualisation, the use of furosemide, or the incidence of positive urine culture at 1 week after surgery.Conclusions: Both preoperative vitamin B2 and intraoperative cystoscopy distension with D5W are highly available and inexpensive methods to detect ureteric jets with high accuracy at the time of pelvic reconstructive surgery. Vitamin B2 was shown to have lower rates of fluorescein rescue for visualisation and higher rates of surgeon satisfaction.
- 5 January 2023
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 130 (6) , 610-618
Comparing vitamin B2 versus 5% dextrose in water for optimal ureteric jet visualisation at the time of pelvic reconstructive surgery: A randomised controlled trial
Objective: To compare preoperative vitamin B2 versus intraoperative cystoscopy distension using 5% dextrose in water (D5W) for ureteric jet visualisation during pelvic reconstructive surgery.Design: Double‐blinded, randomised controlled trial.Setting: Three tertiary hospitals in Toronto, Canada.Population: Adult women undergoing pelvic reconstructive surgery.Methods: Patients were randomised to receive 100 mg of vitamin B2 preoperatively versus bladder distension with D5W intraoperatively.Main outcomes: The primary outcome was the rate of accurate detection of bilateral ureteric jets during cystoscopy. Secondary outcomes included the time elapsed until visualisation, use of intravenous furosemide or fluorescein to assist with visualisation, surgeon satisfaction, and positive urine culture 1 week after surgery.Results: The intervention was completed by 236 patients (vitamin B2 n = 117, D5W n = 119). Preoperative characteristics were similar across groups. Accurate detection of both ureteric jets was high in both groups (vitamin B2 97.4% vs. D5W 90.8%, p = 0.051). The vitamin B2 group had significantly lower use of fluorescein rescue compared with the D5W group (3.4% vs. 11.8%, respectively, p = 0.025). Surgeon satisfaction while using vitamin B2 was significantly higher (p < 0.001). There were no significant differences in the time elapsed until visualisation, the use of furosemide, or the incidence of positive urine culture at 1 week after surgery.Conclusions: Both preoperative vitamin B2 and intraoperative cystoscopy distension with D5W are highly available and inexpensive methods to detect ureteric jets with high accuracy at the time of pelvic reconstructive surgery. Vitamin B2 was shown to have lower rates of fluorescein rescue for visualisation and higher rates of surgeon satisfaction.
- 25 June 2022
- Published by Springer Nature in International Urogynecology Journal
- Vol. 34 (2) , 473-483
Pelvic floor symptoms in cisgender women with Ehlers–Danlos syndrome: an international survey study
Introduction and hypothesis Ehlers–Danlos Syndrome (EDS) is a group of inherited connective tissue disorders associated with abnormal collagen, and is more prevalent in women than in men. The aim of this cross-sectional study was to characterize pelvic floor symptoms in cisgender women with EDS and to describe their impact on quality of life. Methods An online questionnaire on obstetric and gynecological experiences of cisgender women with EDS was disseminated through EDS patient societies and social media. This study was a sub-analysis of the broader questionnaire and focused on pelvic floor disorders, whereby self-reported symptoms and validated questionnaires were used to assess pelvic floor symptom severity (Pelvic Floor Distress Inventory, PFDI-20), impact on quality of life (Pelvic Floor Impact Questionnaire, PFIQ-7), and sexual function (Female Sexual Function Index, FSFI-6). Groups based on age and EDS type were compared using Kruskal–Wallis and Chi-squared tests. Results A total of 1,303 participants were included in the analysis. Pelvic floor symptom prevalence included: stress urinary incontinence in 60%, urgency urinary incontinence in 54%, fecal incontinence in 24%, and pelvic organ prolapse in 21%. Bladder symptoms were reported to be the most bothersome. The impact of prolapse symptoms on quality of life was higher in women under age 40 than in older participants (p<0.001). Pelvic pain was reported in 71%. Pain ratings were highest for dysmenorrhea, muscle and joint pain, and backache (median 7 out of 10 for each). Almost half of participants screened positive for possible sexual dysfunction and 36% reported dyspareunia more than half the time. Conclusions This large, observational study demonstrated that cisgender women with EDS report a high prevalence of pelvic floor symptoms that appear to be more severe than in the general population.
- 25 June 2022
- Published by Springer Nature in International Urogynecology Journal
- Vol. 34 (2) , 473-483
Pelvic floor symptoms in cisgender women with Ehlers–Danlos syndrome: an international survey study
Introduction and hypothesis Ehlers–Danlos Syndrome (EDS) is a group of inherited connective tissue disorders associated with abnormal collagen, and is more prevalent in women than in men. The aim of this cross-sectional study was to characterize pelvic floor symptoms in cisgender women with EDS and to describe their impact on quality of life. Methods An online questionnaire on obstetric and gynecological experiences of cisgender women with EDS was disseminated through EDS patient societies and social media. This study was a sub-analysis of the broader questionnaire and focused on pelvic floor disorders, whereby self-reported symptoms and validated questionnaires were used to assess pelvic floor symptom severity (Pelvic Floor Distress Inventory, PFDI-20), impact on quality of life (Pelvic Floor Impact Questionnaire, PFIQ-7), and sexual function (Female Sexual Function Index, FSFI-6). Groups based on age and EDS type were compared using Kruskal–Wallis and Chi-squared tests. Results A total of 1,303 participants were included in the analysis. Pelvic floor symptom prevalence included: stress urinary incontinence in 60%, urgency urinary incontinence in 54%, fecal incontinence in 24%, and pelvic organ prolapse in 21%. Bladder symptoms were reported to be the most bothersome. The impact of prolapse symptoms on quality of life was higher in women under age 40 than in older participants (p<0.001). Pelvic pain was reported in 71%. Pain ratings were highest for dysmenorrhea, muscle and joint pain, and backache (median 7 out of 10 for each). Almost half of participants screened positive for possible sexual dysfunction and 36% reported dyspareunia more than half the time. Conclusions This large, observational study demonstrated that cisgender women with EDS report a high prevalence of pelvic floor symptoms that appear to be more severe than in the general population.
- 14 June 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (13) , 2203-2213
A risk calculator for postoperative urinary retention (POUR) following vaginal pelvic floor surgery: multivariable prediction modelling
Objective: To determine the perioperative characteristics associated with an increased risk of postoperative urinary retention (POUR) following vaginal pelvic floor surgery.Design: A retrospective cohort study using multivariable prediction modelling.Setting: A tertiary referral urogynaecology unit.Population: Patients undergoing vaginal pelvic floor surgery from January 2015 to February 2020.Methods: Eighteen variables (24 parameters) were compared between those with and without POUR and then included as potential predictors in statistical models to predict POUR. The final model was chosen as the model with the largest concordance index (c‐index) from internal cross‐validation. This was then externally validated using a separate data set (n = 94) from another surgical centre.Main outcome measure: Diagnosis of POUR following surgery while the patient was in hospital.Results: Among the 700 women undergoing surgery, 301 (43%) experienced POUR. Preoperative variables with statistically significant univariate relationships with POUR included age, menopausal status, prolapse stage and uroflowmetry parameters. Significant perioperative factors included estimated blood loss, volume of intravenous fluid administered, operative time, length of stay and specific procedures, including vaginal hysterectomy with intraperitoneal vault suspension, anterior colporrhaphy, posterior colporrhaphy and colpocleisis. The lasso logistic regression model had the best combination of internally cross‐validated c‐index (0.73, 95% CI 0.71–0.74) and a calibration curve that showed good alignment between observed and predicted risks. Using this data, a POUR risk calculator was developed (https://pourrisk.shinyapps.io/POUR/).Conclusions: This POUR risk calculator will allow physicians to counsel patients preoperatively on their risk of developing POUR after vaginal pelvic surgery and help focus discussion around potential management options.
- 14 June 2022
- Published by Wiley in BJOG: An International Journal of Obstetrics & Gynaecology
- Vol. 129 (13) , 2203-2213
A risk calculator for postoperative urinary retention (POUR) following vaginal pelvic floor surgery: multivariable prediction modelling
Objective: To determine the perioperative characteristics associated with an increased risk of postoperative urinary retention (POUR) following vaginal pelvic floor surgery.Design: A retrospective cohort study using multivariable prediction modelling.Setting: A tertiary referral urogynaecology unit.Population: Patients undergoing vaginal pelvic floor surgery from January 2015 to February 2020.Methods: Eighteen variables (24 parameters) were compared between those with and without POUR and then included as potential predictors in statistical models to predict POUR. The final model was chosen as the model with the largest concordance index (c‐index) from internal cross‐validation. This was then externally validated using a separate data set (n = 94) from another surgical centre.Main outcome measure: Diagnosis of POUR following surgery while the patient was in hospital.Results: Among the 700 women undergoing surgery, 301 (43%) experienced POUR. Preoperative variables with statistically significant univariate relationships with POUR included age, menopausal status, prolapse stage and uroflowmetry parameters. Significant perioperative factors included estimated blood loss, volume of intravenous fluid administered, operative time, length of stay and specific procedures, including vaginal hysterectomy with intraperitoneal vault suspension, anterior colporrhaphy, posterior colporrhaphy and colpocleisis. The lasso logistic regression model had the best combination of internally cross‐validated c‐index (0.73, 95% CI 0.71–0.74) and a calibration curve that showed good alignment between observed and predicted risks. Using this data, a POUR risk calculator was developed (https://pourrisk.shinyapps.io/POUR/).Conclusions: This POUR risk calculator will allow physicians to counsel patients preoperatively on their risk of developing POUR after vaginal pelvic surgery and help focus discussion around potential management options.
- 8 July 2021
- Published by Springer Nature in International Urogynecology Journal
- Vol. 32 (8) , 2307
Response to commentary
- 8 July 2021
- Published by Springer Nature in International Urogynecology Journal
- Vol. 32 (8) , 2307
Response to commentary
- 1 July 2021
- Published by Wolters Kluwer Health in Journal of Wound, Ostomy & Continence Nursing
- Vol. 48 (4) , 319-324
What Do Nurses Prefer? A Cross-sectional Study of Catheter Preference After Pelvic Organ Prolapse Surgery
PURPOSE: The purpose of this study was to determine nursing preferences regarding catheter type (transurethral indwelling catheters vs intermittent catheterization vs suprapubic tube drainage) when caring for patients in hospital after pelvic organ prolapse surgery. DESIGN: Cross-sectional survey study. SUBJECTS AND SETTING: Registered nurses practicing in academic and community hospitals across North America (the United States and Canada). METHODS: Three hundred fifty-four RNs who routinely care for patients after pelvic organ prolapse surgery from centers across North America were sent an electronic survey between February 2018 and March 2019. The survey comprised 24 questions that collected information on the participants' demographics and their experience with using different catheters in a hospital setting, along with knowledge of and preference for the different catheter types. Descriptive statistics were used to determine catheter preferences of respondents in addition to their catheter rankings according to catheter-related outcomes. RESULTS: One hundred sixty nurses completed the survey, representing a 45% response rate. More than half (63.1%, n = 101) of respondents stated a preference for transurethral indwelling catheters, 23.1% (n = 37) preferred suprapubic tubes, and 10.6% (n = 17) preferred intermittent catheterization. Transurethral indwelling catheters were ranked by nurses as the best catheter type for ease of use and pain/discomfort for patients. Intermittent catheterization was ranked by nurses as the best for lowest malfunction rates and return of bladder function. Suprapubic tubes were ranked by nurses as best for lowest infection rates. CONCLUSIONS: This study has demonstrated that nurses practicing in inpatient care units have a strong preference for transurethral indwelling catheters over intermittent catheterization and suprapubic tubes when caring for patients after pelvic organ prolapse surgery.
- 1 July 2021
- Published by Wolters Kluwer Health in Journal of Wound, Ostomy & Continence Nursing
- Vol. 48 (4) , 319-324
What Do Nurses Prefer? A Cross-sectional Study of Catheter Preference After Pelvic Organ Prolapse Surgery
PURPOSE: The purpose of this study was to determine nursing preferences regarding catheter type (transurethral indwelling catheters vs intermittent catheterization vs suprapubic tube drainage) when caring for patients in hospital after pelvic organ prolapse surgery. DESIGN: Cross-sectional survey study. SUBJECTS AND SETTING: Registered nurses practicing in academic and community hospitals across North America (the United States and Canada). METHODS: Three hundred fifty-four RNs who routinely care for patients after pelvic organ prolapse surgery from centers across North America were sent an electronic survey between February 2018 and March 2019. The survey comprised 24 questions that collected information on the participants' demographics and their experience with using different catheters in a hospital setting, along with knowledge of and preference for the different catheter types. Descriptive statistics were used to determine catheter preferences of respondents in addition to their catheter rankings according to catheter-related outcomes. RESULTS: One hundred sixty nurses completed the survey, representing a 45% response rate. More than half (63.1%, n = 101) of respondents stated a preference for transurethral indwelling catheters, 23.1% (n = 37) preferred suprapubic tubes, and 10.6% (n = 17) preferred intermittent catheterization. Transurethral indwelling catheters were ranked by nurses as the best catheter type for ease of use and pain/discomfort for patients. Intermittent catheterization was ranked by nurses as the best for lowest malfunction rates and return of bladder function. Suprapubic tubes were ranked by nurses as best for lowest infection rates. CONCLUSIONS: This study has demonstrated that nurses practicing in inpatient care units have a strong preference for transurethral indwelling catheters over intermittent catheterization and suprapubic tubes when caring for patients after pelvic organ prolapse surgery.